UCLA Scholars in Oncologic Molecular Imaging(SOMI)

描述（由申请人提供）：UCLA肿瘤分子成像学者（SOMI）是一个多元化的培训计划，汇集了9个部门，主要来自UCLA生命和健康科学，以培养下一代分子成像科学家。肿瘤分子成像是一个快速发展的领域，它结合了细胞/分子生物学、化学、生物医学物理学、生物数学、药理学、成像科学和临床医学等学科，以推进癌症研究、诊断和管理。 加州大学洛杉矶分校分子与医学药理学系（DMMP）和Crump分子成像研究所（CIMI）是帮助推动分子成像领域向前发展的关键参与者。 在加州大学洛杉矶分校琼森综合癌症中心（JCCC）的最初关键种子支持下，加州大学洛杉矶分校帮助分子成像领域迅速发展。 加州大学洛杉矶分校分子成像项目的资金来源现在包括能源部，NCI（P50）体内细胞和分子成像中心（ICMIC）拨款，几个NCI R 01 'a和NCI小动物成像资源计划（SAIRP）拨款。 培养下一代科学家的时机已经成熟，他们可以在完整的生物体中研究癌症生物学/治疗学所需的各个领域之间架起桥梁。 在目前的提案中，我们的目标是通过代表7个项目领域的29名基础科学和临床教师导师组成的多元化小组培养19名博士后研究员，6门正式课程包括分子成像，药理学，癌症生物学，癌症免疫学，病毒学，基因治疗和临床血液学/肿瘤学轮次。 研究员将被招募到一个为期三年的计划，并将完成课程和研究与至少两个导师。 此外，他们将在第三年进行模拟赠款提案，以帮助他们在赠款申请过程中获得经验和信心。 将特别注意招聘少数族裔申请人。 一个培训委员会将仔细监测所有SOMI受训人员的过程，一个咨询委员会将监测整个SOMI方案。 SOMI的毕业生将接受独特的培训，以最先进的技术在生物体背景下研究癌症。 我们正在发展肿瘤分子成像领域。

DESCRIPTION (provided by applicant): The UCLA scholars in Oncologic Molecular Imaging (SOMI) is a diverse training program bringing together 9 Departments, predominantly from the UCLA Life and Health Sciences, in order to train the next generation of molecular imaging scientist. Oncologic molecular imaging is a rapidly growing area which combines the disciplines of cell/molecular biology, chemistry, biomedical physics, biomathematics, pharmacology, imaging sciences, and clinical medicine to advance cancer research, diagnosis and management. The UCLA Department of Molecular & Medical Pharmacology (DMMP) and the Crump Institute for Molecular Imaging (CIMI) are key players in helping to move the field of molecular molecular imaging forward. With initial critical seed support from the UCLA Jonson Comprehensive Cancer Center (JCCC), UCLA has helped to rapidly grow the field of molecular imaging. Funding sources for the molecular imaging program at UCLA now include the Department of Energy, NCI (P50) In Vivo Cellular and Molecular Imigaing Center (ICMIC) grant, Several NCI R01'a, and NCI Small Animal Imaging Resource Program (SAIRP) grant. The time is ripe for training the next generation of scientists that can bridge the various fields needed to study cancer biology/therapeutics in intact living organisms. In the current proposal, our goals are to train 19 post-doctoral fellows through a diverse group of 29 basic science and clinical faculty mentors representing 7 program areas, 6 formal courses in molecular imaging, pharmacology, cancer biology, cancer immunology, virology, gene therapy, and clinical hematology/oncology rounds. Fellows will be recruited into a three year program and will complete coursework and research with at least two mentors. Furthermore, they will do a mock grant proposal in their third year to help them gain experience and confidence in the grant application process. Special attention will be given towards recruiting minority applicants. A Training Committee will carefully monitor the process of all SOMI trainees, and an Advisory Committee will monitor the entire SOMI program. Graduates of SOMI will be uniquely trained to study cancer in an organism context with state-of-the-art technologies. We are evolving area of the oncologic molecular imaging.